rttnews.comSep 10

Burning Rock Biotech Limited Q1 Loss Rises

Burning Rock Biotech Limited (BNR) reported a wider Q1 loss of -RMB18.41 million, or -RMB0.17 per share, compared to -RMB9.70 million, or -RMB0.09 per share, a year ago. Revenue declined 9.3% to RMB134.77 million from RMB148.55 million.

Original reporting

rttnews.com

Published Sep 10, 2026, 12:30 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Sep 10, 2026, 1:30 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefEarnings

Primary signal

MARKET

Neutral

AI market analysis

Mentioned

$BNR

Relevance

6/10

AlphAI data visualization · based on rttnews.com

Decision brief

The 30-second read

Med

Why it matters

The widened loss suggests deteriorating profitability, likely pressuring the stock lower in the short term.

Market read

First‑time earnings disclosure for a micro‑cap biotech; new data may trigger short‑term trading activity.

What to watch

Potential pipeline developments or upcoming regulatory approvals not reflected in the loss figures.

Relevance 6/10Novelty 7/10Timing: after market close

Background

Burning Rock Biotech Limited reported Q1 2026 results showing a deeper loss compared with the prior year.

Market effects

Sector

Biotech earnings disappointment may pressure peer valuations in Chinese biotech sector.

Regional

Limited impact on broader Chinese market; mainly affects small‑cap biotech investors.

Global

Minimal global relevance beyond niche biotech investors.

Counterpoint

What could challenge this read

Loss widening could be a buying opportunity if the market overreacts to short‑term results.

Key entities

company
Burning Rock Biotech Limited
Chinese biotech firm reporting Q1 earnings.

Read at source ← All news

$BNRMed

Burning Rock Biotech Limited: Burning Rock Reports Second Quarter 2026 Financial Results

Burning Rock Biotech (NASDAQ: BNR) reported Q2 2026 revenues of RMB134.7M (US$19.9M), down 9.3% YoY. Central lab revenue fell 10%, while in-hospital revenue rose 7.4%. Gross profit decreased 9.5% to RMB97.8M. The company expects new product approvals to drive future growth. Cash reserves stood at RMB419.1M as of June 30, 2026.

finanznachrichten.deSep 10

$BNRMed

Burning Rock Biotech Ltd (BNR): Financial results for Q2 2026

Burning Rock Biotech Ltd (BNR) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Burning Rock Reports Second Quarter 2026 Financial Results GUANGZHOU, China, September 10, 2026—Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next-generation sequencing (NGS) technology in the fie

SEC EDGAR 6-KSep 10

$TEOMedAI 8/10

Telecom Argentina Stet - France Telecom Q3 Earnings Call Highlights

Telecom Argentina (NYSE:TEO) reported Q3 capital expenditures of $350M, with net debt decreasing 9% YoY to $2.9B. 5G sites expanded to 1,900. Postpaid mobile lines grew 1% YoY, broadband increased 2.5%, and pay TV grew nearly 5%. EBITDA margin excluding TMA exceeded 42%. The company agreed to a $400M divestment with Metrotel, aiming for future integration.

finance.yahoo.comNov 15

LowAI 8/10

CoreWeave’s Results Foretell Impending Consolidation In AI Neocloud Sector

CoreWeave reported record Q3 revenue of $3.66B, up 168% YoY, and raised its full-year outlook. However, it also reported a net loss of $709M, $846M in interest expense, and plans $39B in 2026 capex. Its debt grew to $46.8B by Q3 2026. CoreWeave's growth relies on significant financing, raising concerns about the neocloud business model's sustainability and potential consolidation.

finance.yahoo.comNov 15

$CRDOMed

Credo Technology outpaces Broadcom in AI networking growth

Credo Technology Group reported fiscal 2026 revenue of $1.3B, up 206% YoY, with non-GAAP EPS rising 392% to $3.46. The company's growth is driven by AI networking products, including active electrical cables. Credo's stock gained 74% YTD. Broadcom's AI chip revenue grew 221% YoY to $16.7B in one quarter. Credo expects over 80% revenue growth in fiscal 2027, with optical revenue exceeding $600M.

cryptobriefing.comNov 15

$RYAAYMedAI 8/10

Wizz Air's Profit Fell 67%. Ryanair's Fell Just 15%

Wizz Air's H1 profit fell 67% to €108.1M on 14% revenue growth, while Ryanair's profit dropped 15% to €2.15B on 3% revenue growth. Wizz faced higher fuel costs and grounded aircraft, while Ryanair benefited from better fuel hedging and fleet management. Both airlines cited fuel costs as a major factor.

liveandletsfly.comNov 15